Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

43.17
Delayed Data
As of Jul 22
 +0.13 / +0.30%
Today’s Change
36.00
Today|||52-Week Range
51.74
-3.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line580.0M767.0M316.0M--
 
 
 
 
Depreciation383.0M366.0M347.0M--
 
 
 
 
Total Other Cash Flow27.0M22.0M629.0M--
 
 
 
 
Funds From Operations990.0M1.2B1.3B--
 
 
 
 
Extraordinary Items--0.00-25.0M--
 
 
Funds From/For Other Operating Expenses-205.0M327.0M1.4B--
 
 
 
 
Net Cash Flow - Operating Activities1.2B828.0M-93.0M--
 
 
 
 
 
InvestingIncrease In Investments-570.0M-2.3B----
 
 
 
Decrease In Investments----446.0M--
 
 
Capital Expenditures-411.0M-248.0M-243.0M--
 
 
 
 
Fixed Asset Disposal0.00-2.3B25.0M--
 
 
 
Net Assets From Acquisitions -231.0M0.00----
 
 
Other Investing - Uses0.000.00-2.0M--
 
 
Other Investing - Sources15.0M9.0M0.00--
 
 
 
Net Cash Flow Investing-1.2B1.6B226.0M--
 
 
 
 
 
FinancingShort Term Borrowings-501.0M738.0M-583.0M--
 
 
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-3.0M-21.0M-7.0M--
 
 
 
 
Net Proceeds Stock Sale50.0M51.0M87.0M--
 
 
 
 
Common Preferred Redeemed-2.0M-888.0M-519.0M--
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-359.0M-360.0M-385.0M--
 
 
 
 
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.0017.0M25.0M--
 
 
 
Net Cash Flow - Financing-815.0M-497.0M-1.4B--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-99.0M-28.0M-368.0M--
 
 
 
 
 
Net Change In Cash-817.0M1.9B-1.3B0.00